Preoperative Stereotactic Radiotherapy for Spinal Metastases: Study Protocol for a Prospective Exploratory Interventional Trial

BACKGROUND AND OBJECTIVES: Spinal metastases frequently require surgical stabilization and/or decompression followed by postoperative radiotherapy (RT). Preoperative stereotactic body radiotherapy (SBRT) may reduce postoperative complications and improve local tumor control. The primary objective of this exploratory trial is to evaluate safety and preliminary efficacy of preoperative SBRT in patients with spinal metastases. METHODS: The Preoperative Stereotactic Radiotherapy for Spinal Metastases study is a single-center, prospective, exploratory, interventional trial that will enroll 20 patients scheduled for surgical treatment of spinal metastases at University Medical Center Göttingen. Patients will receive SBRT (1-3 fractions) performed 1 to 3 days before surgery. The primary endpoint is local tumor control at 3 months after surgery. Secondary endpoints include pain control, wound healing disturbances, quality of life, neurological function, and instrumentation failure. EXPECTED OUTCOMES: The study is expected to provide first prospective data on the feasibility and safety of integrating preoperative SBRT into the treatment sequence for spinal metastases. It will also generate early evidence on local tumor control, perioperative morbidity, patient-reported outcomes, and instrumentation-related outcomes. DISCUSSION: Preoperative Stereotactic Radiotherapy for Spinal Metastases evaluates a novel treatment sequence intended to address limitations of postoperative RT, including delayed treatment initiation and implant-related planning challenges. The rationale is supported by preoperative SBRT approaches for brain metastases, where treatment of the intact lesion before resection has been investigated to improve target definition and avoid irradiation of postoperative cavities. The study is intended to generate initial feasibility, safety, and preliminary efficacy data that may inform the design of a subsequent randomized trial comparing preoperative with postoperative RT.

Authors

Institutions

Publication Details

Journal
Neurosurgery Open
Published
2026-11-12
DOI
https://doi.org/10.1227/neuprac.0000000000000316
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preoperative Stereotactic Radiotherapy for Spinal Metastases: Study Protocol for a Prospective Exploratory Interventional Trial

Andrea Hille, Tammam Abboud, Bilal Younes, Rami Ateyah El Shafie et al.
Neurosurgery Open
Management of metastatic bone disease
article

Preoperative Stereotactic Radiotherapy for Spinal Metastases: Study Protocol for a Prospective Exploratory Interventional Trial

Andrea Hille, Tammam Abboud, Bilal Younes, Rami Ateyah El Shafie, Sandra Donath, Manuel Guhlich, Jan Oelmann, Torge Huckhagel, Laura Anna Fischer, Veit Rohde, Daniela Schmitt, Carla Marie Zwerenz, Lucas Weiser, Leif H. Dröge, Stefan Rieken, Thomas Asendorf, Stephanie Bendrich, Wolfgang Lehmann
article en

Abstract

BACKGROUND AND OBJECTIVES: Spinal metastases frequently require surgical stabilization and/or decompression followed by postoperative radiotherapy (RT). Preoperative stereotactic body radiotherapy (SBRT) may reduce postoperative complications and improve local tumor control. The primary objective of this exploratory trial is to evaluate safety and preliminary efficacy of preoperative SBRT in patients with spinal metastases. METHODS: The Preoperative Stereotactic Radiotherapy for Spinal Metastases study is a single-center, prospective, exploratory, interventional trial that will enroll 20 patients scheduled for surgical treatment of spinal metastases at University Medical Center Göttingen. Patients will receive SBRT (1-3 fractions) performed 1 to 3 days before surgery. The primary endpoint is local tumor control at 3 months after surgery. Secondary endpoints include pain control, wound healing disturbances, quality of life, neurological function, and instrumentation failure. EXPECTED OUTCOMES: The study is expected to provide first prospective data on the feasibility and safety of integrating preoperative SBRT into the treatment sequence for spinal metastases. It will also generate early evidence on local tumor control, perioperative morbidity, patient-reported outcomes, and instrumentation-related outcomes. DISCUSSION: Preoperative Stereotactic Radiotherapy for Spinal Metastases evaluates a novel treatment sequence intended to address limitations of postoperative RT, including delayed treatment initiation and implant-related planning challenges. The rationale is supported by preoperative SBRT approaches for brain metastases, where treatment of the intact lesion before resection has been investigated to improve target definition and avoid irradiation of postoperative cavities. The study is intended to generate initial feasibility, safety, and preliminary efficacy data that may inform the design of a subsequent randomized trial comparing preoperative with postoperative RT.

Neurosurgery OpenVol. 7(6)
Universität Hamburg (DE), University Medical Center Hamburg-Eppendorf (DE), Universitätsmedizin Göttingen (DE), University of Göttingen (DE)
Good health and well-being
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon